Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases

Explore clinical trials studying Eye Diseases. Study availability and eligibility vary by location and protocol.

10,583 public trials 1,307 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases trial results

Completed

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

NCT03038880

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +10 more
Locations
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • Retina Associates Southwest PC Tucson, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 25 locations
View Trial Details
Completed

RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

NCT03633084

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Stanford University Stanford, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View Trial Details
Completed

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

NCT01526889

Conditions
Eye Diseases, Non-infectious Intermediate Uveitis, Non-infectious Panuveitis, +4 more
Locations
  • Novartis Investigative Site Golden, Colorado, United States
  • Novartis Investigative Site Marietta, Georgia, United States
  • Novartis Investigative Site Cambridge, Massachusetts, United States
  • Novartis Investigative Site Omaha, Nebraska, United States
View Trial Details
Completed

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome

NCT02291029

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Mineola, New York, United States
  • Novartis Investigative Site Duncansville, Pennsylvania, United States
  • Novartis Investigative Site Berlin, Germany
View Trial Details
Completed

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

NCT01527500

Conditions
Age-Related Macular Degeneration, Blindness, Eye Diseases, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 19 locations
View Trial Details

Related conditions